City
Epaper

Scientists find protein to block muscle fatigue in long Covid, Alzheimer's

By IANS | Updated: July 14, 2024 13:20 IST

New Delhi, July 14 US researchers have identified a protein responsible for causing fatigue in people with long ...

Open in App

New Delhi, July 14 US researchers have identified a protein responsible for causing fatigue in people with long Covid, Alzheimer's and other diseases.

While infections and neurodegenerative diseases like Alzheimer’s are known to cause inflammation in the brain, the patients often develop muscle problems that seem to be independent of the central nervous system.

A team led by the Washington University School of Medicine in St. Louis found that it is caused by a specific protein that travels from the brain to the muscles and leads to loss of muscle function.

The study, conducted in fruit flies and mice, also identified ways to block this process. This may help physicians treat or prevent muscle wasting caused by bacterial infections, Alzheimer's disease, and long Covid.

Aaron Johnson, Associate professor of developmental biology explained that when people are ill, "messenger proteins from the brain travel through the bloodstream and reduce energy levels in skeletal muscle."

The "process reduces energy levels in skeletal muscle, decreasing the capacity to move and function normally", he said, in the study, published in the journal Science Immunology.

For the study, the team modelled three different types of diseases -- an E. coli bacterial infection, a SARS-CoV-2 viral infection, and Alzheimer’s.

They found that when the brain is exposed to inflammation, it builds up damaging chemicals called reactive oxygen species. This causes brain cells to produce an immune-related molecule called interleukin-6 (IL-6), which travels throughout the body via the bloodstream.

In mice, IL-6 was responsible -- and the corresponding protein in fruit flies -- for reducing energy production in muscles' mitochondria, known as the cells' energy factories.

They also found that IL-6 activates what is called the JAK-STAT pathway in muscle, and this is what causes the reduced energy production of mitochondria.

Currently, several therapeutics already approved by the Food and Drug Administration for other diseases can block this pathway, the team said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

NationalGujarat: Saksham Yuvika Project empowering adolescent girls

NationalBSF steps up vigil along India-Bangladesh border amid fresh unrest in neighbouring country

InternationalUAE signs agreement with UNHCR to support humanitarian response for those affected by conflict in Sudan

MaharashtraMaharashtra Local Body Election Results 2025: “Such a Victory Has Not Been Seen in 30–35 Years,” Says Devendra Fadnavis

InternationalOver 5,400 Afghan refugees deported from Iran, Pakistan in single day

Technology Realted Stories

TechnologySimpler laws, trust-based governance key to India’s growth: FM Sitharaman

TechnologyNHPC to start commercial operations of Subansiri Project’s 2nd unit on Dec 23

TechnologyIndian startup funding jumps 2.6X to $364 million this week

TechnologyUltraTech Cement faces Rs 390 crore GST demand

TechnologyIndia’s biogas sector likely to attract Rs 5,000 crore investment in 2026-27